title: Phosphoenolpyruvate-dependent inhibition of collagen biosynthesis, alpha2beta1 integrin and IGF-I receptor signaling in cultured fibroblasts.
abstract: The mechanism of collagen biosynthesis regulation is not fully understood. The finding that prolidase plays an important role in collagen biosynthesis and phosphoenolpyruvate inhibits prolidase activity "in vitro" led to evaluate its effect on collagen biosynthesis in cultured human skin fibroblasts. Confluent fibroblasts were treated with millimolar concentrations (1-4 mM) of phosphoenolpyruvate monopotassium salt (PEP) for 24 h. It was found that PEP-dependent decrease in prolidase activity and expression was accompanied by parallel decrease in collagen biosynthesis. However, the experiments with inhibitor of PEP production, 3-mercaptopicolinate revealed no direct correlation between collagen biosynthesis and prolidase activity and expression. Since insulin-like growth factor (IGF-I) is the most potent stimulator of both collagen biosynthesis and prolidase activity, and prolidase is regulated by beta(1) integrin signaling, the effect of PEP on IGF-I receptor (IGF-IR) and beta(1) integrin receptor expressions were evaluated. It was found that the exposure of the cells to 4 mM PEP contributed to a decrease in IGF-IR and beta(1) integrin receptor expressions. The data suggest that PEP-dependent decrease of collagen biosynthesis in cultured human skin fibroblasts may undergo through depression of alpha(2)beta(1) integrin and IGF-IR signaling. The hypothetical mechanism of the role of prolidase in IGF-IR, beta(1) integrin receptor expressions, and clinical significance of the process are discussed.
authors.affiliation: Department of Medicinal Chemistry, Medical University in Bialystok, Kilińskiego 1, Bialystok, Poland.
authors.forename: Ewa
authors.initials: E
authors.lastname: Karna
authors.forename: Jerzy A
authors.initials: JA
authors.lastname: Palka
mesh_terms: D015153:Blotting, Western; D002478:Cells, Cultured; D003094:Collagen / Q000096:biosynthesis*; D004150:Dipeptidases / Q000378:metabolism; D005347:Fibroblasts / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism*; D006801:Humans; D038982:Integrin alpha2beta1 / Q000378:metabolism*; D008954:Models, Biological; D010728:Phosphoenolpyruvate / Q000494:pharmacology*; D019764:Phosphoenolpyruvate Carboxykinase (ATP) / Q000378:metabolism; D011392:Proline / Q000378:metabolism; D017526:Receptor, IGF Type 1 / Q000378:metabolism*; D015398:Signal Transduction / Q000187:drug effects*; D012867:Skin / Q000166:cytology / Q000201:enzymology; D014316:Tritium
chemical_list: D038982:Integrin alpha2beta1; D014316:Tritium; D010728:Phosphoenolpyruvate; D003094:Collagen; D011392:Proline; D017526:Receptor, IGF Type 1; D004150:Dipeptidases; C022449:proline dipeptidase; D019764:Phosphoenolpyruvate Carboxykinase (ATP)